Cardiovascular safety profile of duloxetine in patients with diabetic peripheral neuropathic pain

被引：0
|
作者：
Kajdasz, D. K.
Walker, D. J.
Raskin, J.
Wernicke, J. F.
Skljarevski, V.
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Eli Lilly Canada, Lilly Res Labs, Scarborough, ON, Canada
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [1] Cardiovascular safety profile of duloxetine in patients with diabetic peripheral neuropathic pain
    Kajdasz, Daniel K.
    Walker, Daniel J.
    Raskin, Joel
    Wernicke, Joachim F.
    DIABETES, 2006, 55 : A138 - A138
  • [2] Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions
    Wernicke, Joachim F.
    Prakash, Apurva
    Kajdasz, Daniel K.
    Houston, John
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (05) : 349 - 359
  • [3] Duloxetine for the management of diabetic peripheral neuropathic pain: Response profile
    Pritchett, Yili L.
    McCarberg, Bill H.
    Watkin, John G.
    Robinson, Michael J.
    PAIN MEDICINE, 2007, 8 (05) : 397 - 409
  • [4] Duloxetine in the management of diabetic peripheral neuropathic pain: Response profile
    Schmitt, H.
    Pritchett, Y. L.
    McCarberg, B. H.
    Watkin, J. G.
    Robinson, M. J.
    DIABETOLOGIA, 2006, 49 : 670 - 671
  • [5] Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients
    Wasan, Ajay D.
    Ossanna, Melissa J.
    Raskin, Joel
    Wernicke, Joachim F.
    Robinson, Michael J.
    Hall, Jerry A.
    Edwards, Sara E.
    Lipsius, Sarah
    Meyers, Adam L.
    McCarberg, Bill H.
    CURRENT DRUG SAFETY, 2009, 4 (01) : 22 - 29
  • [6] Duloxetine in the management of diabetic peripheral neuropathic pain
    Ormseth, Michelle J.
    Scholz, Beth A.
    Boomershine, Chad S.
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 343 - 356
  • [7] Safety profile of treatment in diabetic peripheral neuropathic pain
    Robinson-Papp, Jessica
    Simpson, David M.
    PAIN MEDICINE, 2007, 8 : S43 - S49
  • [8] Duloxetine in the treatment of diabetic peripheral neuropathic pain
    Goldstein, David J.
    FUTURE NEUROLOGY, 2006, 1 (06) : 700 - 711
  • [9] Duloxetine for the management of diabetic peripheral neuropathic pain: Safety and tolerability in patients with baseline comorbid conditions
    Robinson, M
    Hardy, T
    Prakash, A
    Rosen, A
    Shen, S
    Wernicke, JF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S128 - S128
  • [10] EVALUATING THE MAINTENANCE OF EFFECT OF DULOXETINE IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN
    Kelin, Katarina
    Skljarevski, Vladimir
    Desaiah, Durisala
    Zhang, Qi
    Chappell, Amy S.
    Detke, Michael J.
    Gross, Jorge L.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 : A57 - A57
12345